![Thomas Wiggans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Wiggans
Vorsitzender bei
JASPER THERAPEUTICS, INC.
Vermögen: 38 134 $ am 31.05.2026
Profil
Thomas G.
Wiggans is the founder of Dermira, Inc., founded in 2010.
Current jobs include Chairman at The Biotechnology Institute, Executive Chairman at Follica, Inc. since 2021, Executive Chairman at Jasper Therapeutics, Inc. starting 2026, Director at Forma Therapeutics, Inc., Director at The Hoover Institution, Independent Director at Pacira Biosciences, Inc. starting 2026, Trustee at Kansas University Endowment Association, Trustee at Kansas Association of Defense Counsel, and Trustee at Wiggans Living Trust.
Former jobs include Chairman & Chief Executive Officer at Connetics Corp.
(1994–2006), Chairman & Chief Executive Officer at Peplin, Inc. (2007–2009), Chairman & Chief Executive Officer at Pardes Biosciences, Inc. (2022–2023), Chairman at Excaliard Pharmaceuticals, Inc. (2010–2011), Chairman at Annexon, Inc. (2017–2026), Independent Director at Onyx Pharmaceuticals, Inc. (2005–2013), Director at Abgenix, Inc., Independent Director at Sangamo Therapeutics, Inc. (2008–2012), Director at Corthera, Inc., Director at Tercica, Inc. (2005–2006), Independent Director at Somaxon Pharmaceuticals, Inc. (2008–2012), Independent Director at Forma Therapeutics Holdings, Inc. (2020–2022), Director at Victory Pharma, Inc., Director at Neothetics, Inc. (2011–2014), Independent Director at CymaBay Therapeutics, Inc. (2021–2024), Director at Biotechnology Innovation Organization, Principal at Eli Lilly & Co., President & Chief Operating Officer at CytoTherapuetics, Inc. (1992–1994), and President-US Pharmaceutical Operations at Ares-Serono Group (1980–1992).
Education includes an MBA from Southern Methodist University conferred in 1976 and an undergraduate degree from the University of Kansas conferred in 1975.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 46.000 ( 0,16 % ) | 38 134 $ | 31.05.2026 | |
ANNEXON, INC. -.--% | 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Thomas Wiggans
| Unternehmen | Position | Beginn |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Vorsitzender | 01.11.2023 |
| PACIRA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 09.06.2026 |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Direktor/Vorstandsmitglied | - |
Follica, Inc.
 Follica, Inc. Other Consumer ServicesConsumer Services Develops therapies for hair follicle disorders | Vorsitzender | 14.01.2021 |
Wiggans Living Trust | Direktor/Vorstandsmitglied | - |
Kansas Association of Defense Counsel
 Kansas Association of Defense Counsel Miscellaneous Commercial ServicesCommercial Services The Kansas Association of Defense Counsel (KADC) is a statewide non-profit organization of lawyers based in Topeka, KS. The KADC consists of over 230 attorneys who specialize in the civil defense of litigated cases. The company's goal is to enhance the knowledge and improve the skills of defense lawyers, elevate the standards of trial practice, and work for the administration of justice. | Direktor/Vorstandsmitglied | 29.07.2009 |
The Hoover Institution
 The Hoover Institution Miscellaneous Commercial ServicesCommercial Services Operates as research center dedicated to supporting knowledge in economics, politics, history and public policy | Direktor/Vorstandsmitglied | 29.07.2009 |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services Focuses on biotechnological research | Vorsitzender | - |
Kansas University Endowment Association
 Kansas University Endowment Association Miscellaneous Commercial ServicesCommercial Services Operates as fundraising foundation | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Thomas Wiggans
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Thomas Wiggans
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
31
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 31 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Corthera, Inc.
 Corthera, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for illnesses in the acute care setting | Health Technology |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Peplin, Inc.
 Peplin, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
CytoTherapuetics, Inc.
 CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
University of Kansas
 University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ares-Serono Group
 Ares-Serono Group Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Kansas University Endowment Association
Kansas University Endowment Association Miscellaneous Commercial ServicesCommercial Services Operates as fundraising foundation | Commercial Services |
The Hoover Institution
The Hoover Institution Miscellaneous Commercial ServicesCommercial Services Operates as research center dedicated to supporting knowledge in economics, politics, history and public policy | Commercial Services |
The Biotechnology Institute
The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services Focuses on biotechnological research | Commercial Services |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutics for the treatment of scarring & fibrotic disorders | Health Technology |
Follica, Inc.
Follica, Inc. Other Consumer ServicesConsumer Services Develops therapies for hair follicle disorders | Consumer Services |
Victory Pharma, Inc.
 Victory Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures prescription pharmaceutical products | Health Technology |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic | Health Technology |
Kansas Association of Defense Counsel
Kansas Association of Defense Counsel Miscellaneous Commercial ServicesCommercial Services The Kansas Association of Defense Counsel (KADC) is a statewide non-profit organization of lawyers based in Topeka, KS. The KADC consists of over 230 attorneys who specialize in the civil defense of litigated cases. The company's goal is to enhance the knowledge and improve the skills of defense lawyers, elevate the standards of trial practice, and work for the administration of justice. | Commercial Services |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Wiggans Living Trust | |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Wählen Sie MarketScreener 
